CONCLUSIONS: Our results are very promising and statistically significant. We found improved erections on ultrasound and by patient reporting. The majority of patients expressed satisfaction with overall results following injections. Previously, safety data from multiple institutions has been reported on ProFlo Amniotic Fluid. This is the first study to evaluate the effectiveness of ProFlo AF injections. ProFlo AF needs larger studies but may prove to be a safe, effective and noninvasive treatment in men with ED. 
INTRODUCTION AND OBJECTIVES:
The aim of this study was to investigate whether intracavernous injection of urine-derived stem cells (USCs) or USCs overexpressing pigment epithelium-derived factor (PEDF) could protect the erectile function and cavernous structure in a bilateral cavernous nerve injury-induced erectile dysfunction (CNIED) rat model. METHODS: USCs were cultured from the urine of eight healthy male donors. Seventy-five rats were randomly divided into five groups (n ¼ 15 per group): sham, bilateral cavernous nerve (CN) crush injury (BCNI), USC, GFP-USC , and PEDF-USC groups. The sham group received only laparotomy without CN crush injury and intracavernous injection with phosphate-buffered saline (PBS). All of the other groups were subjected to BCNI and intracav-ernous injection with PBS, USCs, GFP-USCs, or GFP/PEDF-USCs, respectively. The total intracavernous pressure (ICP) and the ratio of ICP to mean arterial pressure (ICP/MAP) were recorded. The penile dorsal nerves, the endothelium, and the smooth muscle were assessed within the penile tissue.
RESULTS: The penile dorsal nerves, the endothelium, and the smooth muscle were assessed within the penile tissue. The USC and PEDF-USC groups displayed more significantly enhanced ICP and ICP/MAP ratio (p < 0.05) 28 days after cell transplantation. Immunohistochemistry (IHC) and Western blot analysis demonstrated that the protection of erectile function and the cavernous structure by PEDF-USC was associated with an increased number of nNOS-positive fibers within the penile dorsal nerves, improved expression of endothelial markers (CD31 and eNOS) and smoothelin, an enhanced smooth muscle to collagen ratio, decreased expression of TGF-b1, and decreased cell apoptosis in the cavernous tissue.
CONCLUSIONS: The paracrine effect of USCs and PEDFUSCs prevented the destruction of erectile function and the cavernous structure in the CNIED rat model by nerve protection, thereby improving endothelial cell function, increasing the smooth muscle content, and decreasing fibrosis and cell apoptosis in the cavernous tissue.
Source of Funding: the National Natural Science Foundation of China (Nos. 81471449, and 81401197)
MP41-15 STEM CELL ACTIVATION IN THE MAJOR PELVIC GANGLION IS ENHANCED BY STROMAL DERIVED FACTOR-1 PENILE INJECTIONS FOLLOWING NERVE INJURY
Nikolai Sopko*, Baltimore, MD; Hotaka Matsui, Tokyo, Japan; Takahiro Yoshida, Xiaopu Liu, Max Kates, Trinity Bivalacqua, Baltimore, MD INTRODUCTION AND OBJECTIVES: Stem cells are believed to play a role in nerve regeneration following nerve injury. Stromal Derived Factor-1 (SDF1) is potent stem cell chemokine. We investigated whether penile injections with SDF1 following bilateral nerve crush injury (BCNI) can enhance stem cell recruitment and activation in the major pelvic ganglion (MPG).
METHODS: Sprague Dawley (350g) male rats underwent sham procedure or BCNI (n¼10/group). Starting on the day of surgery, BCNI animals received penile injections with 1ug of SDF1 or saline QOD for 5 injections. Sham animals received saline penile injections only. 2 weeks after BCNI, intracorporeal pressure (ICP) response to cavernous nerve stimulation was assessed (n¼5/ group) and MPGs were collected and RNA was isolated (n¼5/ group). Stem cell activity in the MPG was assessed using a stem cell expression array expressed as mean fold-change AE SE normalized to sham.
RESULTS: SDF1 penile injections resulted in improved ICP preservation following BCNI compared to animals receiving saline injections. Sham animals had significantly greater (P<0.05, 1-way ANOVA with Tukey's post-hoc testing) than BCNI+saline at all voltages (2, 4, 6, 8v), whereas there was no significant difference between Sham and BCNI+SDF1 at any voltages. Additionally, BCNI+SDF1 had greater ICP at 2v and 4v compared to BCNI+saline (0.40AE0.09 vs. 0.11AE0.08, p<0.05 and 0.47AE0.11 vs. 0.12AE0.08, p<0.05, respectively). Stem cell-associated gene expression normalized to Shams was globally increased following BCNI and BCNI+SDF1 had a greater increase in expression compared to BCNI+saline (7.89AE0.67 fold vs. 1.87AE0.15 fold, p<0.0001). On subset analysis, stem cell pathways had significantly greater expression in BCNI+SDF1 compared to BCNI+saline including cytokines and growth factors (6.45AE0.63 vs. 1.86AE0.13, p<0.0001), Notch pathway (7.72AE0.96 vs. 1.95AE0.17, p<0.0001), Wnt pathway (7.01AE0.68 vs. 1.87AE0.12, p<0.0001), mesenchymal stem cell markers (6.33AE1.16 vs. 1.82AE0.40, p¼0.0015), and neural cell lineage markers (6.63AE0.51 vs. 1.85AE0.14, p¼0.0003).
CONCLUSIONS: SDF1 penile injections improve preservation of erectile function following BCNI and are associated with increased stem cell pathway activation in MPG. METHODS: Twelve-week-old NOD-SCID mice were divided into eight groups: sham operation group, bilateral CNI group receiving a single intracavernous injection of phosphate-buffered saline (20 mL), TSC1 (3 Â 105 cells/20 mL) or TSC2 (6 Â 105 cells/20 mL), NPC1 (3 Â 105 cells/20 mL) or NPC2 (6 Â 105 cells/20 mL), TSC+NPC combination(3 Â 105 cells, each, in total 20 mL), ADMSC2 (6 Â 105 Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e541
